Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1822, Issue 6, 2012, Pages 970-979

  Magagnotti, Cinzia ^a   Bachi, Angela ^a   Zerbini, Gianpaolo ^a   Fattore, Elena ^b   Fermo, Isabella ^a   Riba, Michela ^a   Previtali, Stefano C ^a   Ferrari, Maurizio ^a,c   Andolfo, Annapaola ^a   Benedetti, Sara ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Laminopathies; Mass spectrometry; Muscular dystrophy; Proteomics; Skin fibroblasts

Indexed keywords

CYTOSKELETON PROTEIN; LAMIN A; LAMIN C; STRUCTURAL PROTEIN;

ARTICLE; CELL ENERGY; CONTROLLED STUDY; ENERGY METABOLISM; ENERGY YIELD; FAMILIAL PARTIAL LIPODYSTROPHY; FAMILY HISTORY; GENE; GENE MUTATION; HEART MUSCLE; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMINOPATHY; LMNA GENE; MUSCULAR DYSTROPHY; NEUROMUSCULAR DISEASE; OXIDATIVE STRESS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SKELETAL MUSCLE; SKIN FIBROBLAST; WESTERN BLOTTING;

ADULT; CYTOSKELETAL PROTEINS; ENERGY METABOLISM; FEMALE; FIBROBLASTS; HUMANS; LAMIN TYPE A; MALE; MIDDLE AGED; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; MUTATION; NEUROMUSCULAR DISEASES; NUCLEAR ENVELOPE; NUCLEAR PROTEINS; OXIDATIVE STRESS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; SKIN;

EID: 84859060784     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.01.014     Document Type: Article

References (46)

1. Bonne G., Di Barletta M.R., Varnous S., Bécane H.M., Hammouda E.H., Merlini L., Muntoni F., Greenberg C.R., Gary F., Urtizberea J.A., Duboc D., Fardeau M., Toniolo D., Schwartz K. Mutations in the gene encoding Lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 1999, 21:285-288.
2. Muchir A., Bonne G., van der Kooi A.J., van Meegen M., Baas F., Bolhuis P.A., de Visser M., Schwartz K. Identification of mutations in the gene encoding Lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 2000, 9:1453-1459.
3. De Sandre-Giovannoli A., Chaouch M., Kozlov S., Vallat J.M., Tazir M., Kassouri N., Szepetowski P., Hammadouche T., Vandenberghe A., Stewart C.L., Grid D., Lévy N. Homozygous defects in LMNA, encoding Lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 2002, 70:726-736.
4. Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M., Atherton J., Jr Vidaillet H.J., Spudich S., De Girolami U., Seidman J.G., Seidman C., Muntoni F., Müehle G., Johnson W., McDonough B. Missense mutations in the rod domain of the Lamin A/C gene as causes of dilated cardiomyopathy and conductionsystem disease. N. Engl. J. Med. 1999, 341:1715-1724.
5. Cao H., Hegele R.A. Nuclear Lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 2000, 9:109-112.
6. Novelli G., Muchir A., Sangiuolo F., Helbling-Leclerc A., D'Apice M.R., Massart C., Capon F., Sbraccia P., Federici M., Lauro R., Tudisco C., Pallotta R., Scarano G., Dallapiccola B., Merlini L., Bonne G. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding Lamin A/C. Am. J. Hum. Genet. 2002, 71:426-431.
7. De Sandre-Giovannoli A., Bernard R., Cau P., Navarro C., Amiel J., Boccaccio I., Lyonnet S., Stewart C.L., Munnich A., Le Merrer M., Lévy N. Lamin a truncation in Hutchinson-Gilford progeria. Science 2003, 300:2055.
8. Navarro C.L., Sandre-Giovannoli De A., Bernard R., Boccaccio I., Boyer A., Geneviève D., Hadj-Rabia S., Gaudy-Marqueste C., Smitt H.S., Vabres P., Faivre L., Verloes A., Van Essen T., Flori E., Hennekam R., Beemer F.A., Laurent N., Le Merrer M., Cau P., Lévy N. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum. Mol. Genet. 2004, 13:2493-2503.
9. Benedetti S., Menditto I., Degano M., Rodolico C., Merlini L., D'Amico A., Palmucci L., Berardinelli A., Pegoraro E., Trevisan C.P., Morandi L., Moroni I., Galluzzi G., Bertini E., Toscano A., Olivè M., Bonne G., Mari F., Caldara R., Fazio R., Mammì I., Carrera P., Toniolo D., Comi G., Quattrini A., Ferrari M., Previtali S.C. Phenotypic clustering of lamin A/C mutations in neuromuscular patients. Neurology 2007, 69:1285-1292.
10. Lammerding J., Schulze P.C., Takahashi T., Kozlov S., Sullivan T., Kamm R.D., Stewart C.L., Lee R.T. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J. Clin. Invest. 2004, 113:370-378.
11. Nikolova V., Leimena C., McMahon A.C., Tan J.C., Chandar S., Jogia D., Kesteven S.H., Michalicek J., Otway R., Verheyen F., Rainer S., Stewart C.L., Martin D., Feneley M.P., Fatkin D. Defects in nuclear structure and function promote dilated cardiomyopathy in Lamin A/C-deficient mice. J. Clin. Invest. 2004, 113:357-369.
12. Shumaker D.K., Kuczmarski E.R., Goldman R.D. The nucleoskeleton: lamins and actin are major players in essential nuclear functions. Curr. Opin. Cell Biol. 2003, 15:358-366.
13. Stierlé V., Couprie J., Ostlund C., Krimm I., Zinn-Justin S., Hossenlopp P., Worman H.J., Courvalin J.C., Duband-Goulet I. The carboxyl-terminal region common to lamins A and C contains a DNA binding domain. Biochemistry 2003, 42:4819-4828.
14. Muchir A., Pavlidis P., Bonne G., Hayashi Y.K., Worman H.J. Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum. Mol. Genet. 2007, 16:1884-1895.
15. Muchir A., Pavlidis P., Decostre V., Herron A.J., Arimura T., Bonne G., Worman H.J. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J. Clin. Invest. 2007, 117:1282-1293.
16. Bakay M., Wang Z., Melcon G., Schiltz L., Xuan J., Zhao P., Sartorelli V., Seo J., Pegoraro E., Angelini C., Shneiderman B., Escolar D., Chen Y.W., Winokur S.T., Pachman L.M., Fan C., Mandler R., Nevo Y., Gordon E., Zhu Y., Dong Y., Wang Y., Hoffman E.P. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 2006, 129:996-1013.
17. Andrés V., González J.M. Role of A-type lamins in signaling, transcription, and chromatin organization. J. Cell Biol. 2009, 187:945-957.
18. Méjat A., Decostre V., Li J., Renou L., Kesari A., Hantaï D., Stewart C.L., Xiao X., Hoffman E., Bonne G., Misteli T. Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy. J. Cell Biol. 2009, 84:31-44.
19. Gnocchi V.F., Ellis J.A., Zammit P.S. Does satellite cell dysfunction contribute to disease progression in Emery-Dreifuss muscular dystrophy?. Biochem. Soc. Trans. 2008, 36:1344-1349.
20. Worman H.J., Bonne G. "Laminopathies": a wide spectrum of human diseases. Exp. Cell Res. 2007, 313:2121-2133.
21. Doran P., Donoghue P., O'Connell K., Gannon J., Ohlendieck K. Proteomic profiling of pathological and aged skeletal muscle fibres by peptide mass fingerprinting. Int. J. Mol. Med. 2007, 19:547-564.
22. Lewis C., Jockusch H., Ohlendieck K. Proteomic profiling of the dystrophin-deficient MDX heart reveals drastically altered levels of key metabolic and contractile proteins. J. Biomed. Biotechnol. 2010, 2010. ID 648501.
23. Benedetti S., Bertini E., Iannaccone S., Angelini C., Trisciani M., Toniolo D., Sferrazza B., Carrera P., Comi G., Ferrari M., Quattrini A., Previtali S.C. Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 2005, 76:1019-1021.
24. Westermeier R., Marouga R. Protein detection methods in proteomics research. Biosci. Rep. 2005, 25:19-32.
25. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68:850-858.
26. Magagnotti C., Fermo I., Carletti R.M., Ferrari M., Bachi A. Comparison of different depletion strategies for improving resolution of the human urine proteome. Clin. Chem. Lab. Med. 2010, 48:531-535.
27. Matafora V., D'Amato A., Mori S., Blasi F., Bachi A. Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition. Mol. Cell. Proteomics 2009, 8:2243-2255.
28. King J.Y., Ferrara R., Tabibiazar R., Spin J.M., Chen M.M., Kuchinsky A., Vailaya A., Kincaid R., Tsalenko A., Deng D.X., Connolly A., Zhang P., Yang E., Watt C., Yakhini Z., Ben-Dor A., Adler A., Bruhn L., Tsao P., Quertermous T., Ashley E.A. Pathway analysis of coronary atherosclerosis. Physiol. Genomics 2005, 23:103-118.
29. Maere S., Heymans K., Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21:3448-3449.
30. Eriksson L., Johansson E., Kettaneh-Wold N., Wold S. Introduction to the Multi- and Megavariate Data Analysis Using Projection Methods (PCA & PLS) 1999, Umetrics AB, Umea,Sweden. first ed.
31. Favreau C., Dubosclard E., Ostlund C., Vigouroux C., Capeau J., Wehnert M., Higuet D., Worman H.J., Courvalin J.C., Buendia B. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with Dunnigan-type partial lipodystrophy and Emery-Dreifuss muscular dystrophy. Exp. Cell Res. 2003, 282:14-23.
32. Bechert K., Lagos-Quintana M., Harborth J., Weber K., Osborn M. Effects of expressing lamin A mutant protein causing Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy in HeLa cells. Exp. Cell Res. 2003, 286:75-86.
33. Chen S., Martin C., Maya-Mendoza A., Tang C.W., Lovrić J., Sims P.F., Jackson D.A. Reduced expression of Lamin A/C results in modified cell signaling and metabolism coupled with changes in expression of structural proteins. J. Proteome Res. 2009, 8:5196-5211.
34. Stewart C.L., Kozlov S., Fong L.G., Young S.G. Mouse models of the laminopathies. Exp. Cell Res. 2007, 313:2144-2156.
35. Novelli G., D'Apice M.R. The strange case of the "lumper" Lamin A/C gene and human premature ageing. Trends Mol. Med. 2003, 9:370-375.
36. Vigouroux C., Auclair M., Dubosclard E., Pouchelet M., Capeau J., Courvalin J.C., Buendia B. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the Lamin A/C gene. J. Cell Sci. 2001, 114:4459-4468.
37. -/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum. Mol. Genet. 2004, 13:2567-2580.
38. Lee J.S., Hale C.M., Panorchan P., Khatau S.B., George J.P., Tseng Y., Stewart C.L., Hodzic D., Wirtz D. Nuclear Lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. Biophys. J. 2007, 93:2542-2552.
39. Folker E.S., Ostlund C., Luxton G.W., Worman H.J., Gundersen G.G. Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement. Proc. Natl. Acad. Sci. 2011, 108:131-136.
40. Broers J.L., Ramaekers F.C., Bonne G., Yaou R.B., Hutchison C.J. Nuclear lamins: laminopathies and their role in premature ageing. Physiol. Rev. 2006, 86:967-1008.
41. Hale C.M., Shrestha A.L., Khatau S.B., Stewart-Hutchinson P.J., Hernandez L., Stewart C.L., Hodzic D., Wirtz D. Dysfunctional connections between the nucleus and the actin and microtubule networks in laminopathic models. Biophys. J. 2008, 95:5462-5475.
42. Chen S., Martin C., Maya-Mendoza A., Tang C.W., Lovrić J., Sims P.F., Jackson D.A. Reduced expression of lamin A/C results in modified cell signaling and metabolism coupled with changes in expression of structural proteins. J. Proteome Res. 2009, 8:5196-5211.
43. Boschmann M., Engeli S., Moro C., Luedtke A., Adams F., Gorzelniak K., Rahn G., Mähler A., Dobberstein K., Krüger A., Schmidt S., Spuler S., Luft F.C., Smith S.R., Schmidt H.H., Jordan J. LMNA mutations, skeletal muscle lipid metabolism, and insulin resistance. J. Clin. Endocrinol. Metab. 2010, 95(4):1634-1643.
44. Tidball J.G., Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J. Appl. Physiol. 2007, 102:1677-1686.
45. Charniot J.C., Bonnefont-Rousselot D., Marchand C., Zerhouni K., Vignat N., Peynet J., Plotkine M., Legrand A., Artigou J.Y. Oxidative stress implication in a new phenotype of amyotrophic quadricipital syndrome with cardiac involvement due to lamin A/C mutation. Free. Radic. Res. 2007, 41:424-431.
46. Verstraeten V.L., Caputo S., van Steensel M.A., Duband-Goulet I., Zinn-Justin S., Kamps M., Kuijpers H.J., Ostlund C., Worman H.J., Briedé J.J., Le Dour C., Marcelis C.L., van Geel M., Steijlen P.M., van den Wijngaard A., Ramaekers F.C., Broers J.L. The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress. J. Cell. Mol. Med. 2009, 13:959-971.